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1 Abstract 19 
Post weaning diarrhea (PWD) in pigs is a leading cause of economic loss in pork production 20 
worldwide. The current practice of using antibiotics and zinc to treat PWD is unsustainable due 21 
to the potential of antibiotic resistance and ecological disturbance, and novel methods are 22 
required. In this study, an in vitro model was used to test the possibility of producing prebiotic 23 
fiber in situ in the gastro-intestinal tract (GI-tract) of the piglet and the prebiotic activity of the 24 
resulting fiber in the terminal ileum. Soluble fiber were successfully produced from potato 25 
pulp, an industrial waste product, with a minimal enzyme dose in a simulated upper GI-model 26 
extracting 26.9 % of initial dry matter. The fiber was rich in galactose and galacturonic acid and 27 
was fermented at 2.5, 5 or 10 g/L in a glucose-free media inoculated with the gut contents of 28 
piglet terminal ileum. Fermentations of 5 g/L inulin or 5 g/L of a purified potato fiber were used 29 
as controls. The fibers showed high fermentability, evident by a dose-dependent drop in pH and 30 
increase in organic acids, with lactate in particularly being increased. Deep sequencing showed 31 
a significant increase in Lactobacillus and Veillonella and an insignificant increase in 32 
Clostridium as well as a decrease in Streptococcus. Multivariate analysis showed clustering of 33 
the treatment groups, with the purified potato fiber being clearly separated from the other 34 
groups as the microbiota composition was 60 % Lactobacillus and almost free of Clostridium. 35 
For animal studies, a dosage corresponding to the 5 g/L treatment is suggested. 36 
 37 
 38 
 39 
           3 OF 36 
 
2 Introduction 40 
Post weaning diarrhea (PWD) is a serious condition frequently afflicting piglets after weaning 41 
(1–3) and is a leading cause of economic loss in industrial pork production(4, 5). The pathology 42 
and etiology of PWD is complex, but the causative agent is believed to be enterotoxigenic 43 
Escherichia coli (ETEC) (3, 6, 7). The infective action of ETEC is in turn facilitated by the 44 
immature gastrointestinal system in the piglet, the switch from immunoglobulin-rich maternal 45 
milk to solid foods with lower digestibility, increased emotional stress and the lowered food 46 
intake (3, 4, 7). 47 
A substantial amount of antibiotics as well as the heavy metal zinc are used for prevention and 48 
treatment of PWD, as it is presently the most cost-effective means of improving performance in 49 
swine production (8, 9). However, due to increasing problems with antibiotic resistance in 50 
bacteria of both veterinary and human importance, as well as environmental concerns about the 51 
use of heavy metals, alternative strategies for prevention of PWD are needed.  52 
In humans, it is well established that prebiotic fibers, e.g. indigestible fibers fermented by the 53 
intestinal microbiota such as polymers of fructose or galactose, can result in increased growth 54 
of selected beneficial bacteria from the commensal microbiota (10). It is also known that 55 
various strains of Lactobacillus and Bifidobacterium act as suppressors or inhibitors of 56 
infectious bacteria (11), likely due to production of antimicrobial peptides and organic acids 57 
(OA) as thoroughly reviewed by Liévin-Le Moal & Servin (12). It could then be hypothesized 58 
that prebiotic intervention would increase piglet infection resilience by competitive inhibition 59 
of pathogenic bacteria or general improvement of health status. Studies in animals have, 60 
however, not been conclusive in establishing if the same effect is possible in weaning piglets 61 
(13–17), perhaps because of difficulties in observing an effect in a healthy animal. In contrast, 62 
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studies using experimental infections along with prebiotic intervention generally show a 63 
protective effect against PWD (18–20). In vitro fermentations, using inocula from pig intestines 64 
or pig feces have, however, been fairly successful in showing increases in Lactobacillus and, to 65 
a much lesser extent, Bifidobacterium, and/or increases in production of organic acids (OA) 66 
resulting from bacterial fermentation (21–24).  67 
Potato pulp is a high volume waste product from the starch industry, currently produced at 68 
~1x106 tonnes/year in Europe where it is used in low-value applications, e.g. as in animal feed 69 
priced at ~10 €/ton (25). It has previously been shown that a novel, fermentable and highly 70 
prebiotic fiber could be produced from potato pulp (26, 27), having the potential for use as a 71 
beneficial feed supplement resulting in a substantial increase in the value of potato pulp. These 72 
fibers are tightly bound to the pulp matrix and are insoluble and inaccessible to the gut bacteria 73 
in this state. The fibers consist of the rhamnogalacturonan-1 (RG-1) domain of pectin, e.g. an 74 
alternating backbone of rhamnose and galacturonic acid substituted with galactose and 75 
arabinose chains (28, 29). The pulp is very high in pectin containing this domain and the work 76 
of Thomassen et al. (2011) has shown that a mixture of polygalacturonase (3.2.1.15) and pectin 77 
lyase (4.2.2.10) efficiently released large amounts of RG-1 in an industrially relevant setting 78 
(26).  79 
In a pig, peristalsis and body heat provides natural agitation and constant temperature in the >2 80 
hours required for the feed to reach the terminal small intestine. In light of this, it was 81 
hypothesized that feeding enzymes and substrate should allow the enzymatic degradation of 82 
highly complex molecules into prebiotic fibers in situ, thereby decreasing the issues of 83 
industrial fiber production, such as purification and transport. Release of these fibers from 84 
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potato pulp by the gut microbiota is not possible, as the bacteria in the pig ileum does not 85 
possess genes for pectinolytic enzymes (30). 86 
In this work, the feasibility of executing the enzymatic reaction in an in vitro piglet intestinal 87 
system was evaluated, as well as the effect of these fibers on the microbiota composition in 88 
ileum samples obtained from 26 days old piglets. 89 
3 Materials and methods 90 
3.1 Characterization of pectinolytic enzymes 91 
Pectin lyase and polygalacturonase were produced by fermentations as described in de Silva et 92 
al. (31) using Pichia pastoris clones transformed with the pectin lyase gene AN2569.2 and the 93 
polygalacturonase gene AN4372.2, both from Aspergillus niger as described in Bauer et al. 94 
(32). This method ensures production of mono-component enzymes by placing the gene under 95 
control of a methanol promoter, allowing the enzyme to be expressed in large amounts by 96 
addition of methanol to the fermentation. Protein concentrations were determined by the 97 
bicinchoninic acid assay with bovine serum albumin as a standard as described by the 98 
manufacturer (Thermo Fisher Scientific, Rockford, IL).  99 
Pectin lyase activity was assayed by incubating 0.25 % enzyme-to-substrate [w/w] (%E/S) 100 
pectin lyase with 1.5 g/L citrus pectin (Sigma–Aldrich, Steinhein, Germany) in McIlvaine 101 
buffer at pH 3 or pH 7 at 25 °C in triplicate. The reaction was followed for 10 min in an 102 
Infinite200 Microplate Reader (Tecan, Salzburg, Austria) by recording the absorbance at 235 103 
nm. Units were defined as µmol of unsaturated uronide released per minute using 5500M-1cm-1 104 
as the extinction coefficient (31). 105 
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Polygalacturonase was assayed by incubating 0.125 % E/S with 3 g/L polygalacturonic acid 106 
(Sigma–Aldrich, Steinhein, Germany) in McIlvaine buffer at pH 3 or 7 at 37 °C in triplicate. 107 
The amount of reducing ends was quantified in the reducing ends assay as described in 108 
Thomassen et al. (26). In brief; after 10 min of incubation, the enzymatic reaction was stopped 109 
by extracting 20 µL into a freshly made and preheated PAHBAH solution, which was then 110 
incubated at 70 °C for 10 min. The amount of reducing ends was then quantified by the 111 
absorbance at 410 nm. Units are defined as the released µmoles of galacturonic acid per 112 
minute, using free galacturonic acid as a standard. 113 
3.2 Animals 114 
Five suckling pigs were acquired from a commercial farm in Denmark at 26 days of age, two 115 
days before they would otherwise have been weaned. The animals were females of mixed 116 
breed, had been given a wheat based creep feed since 7 days of age, had furthermore not been 117 
given antibiotics and were healthy.  118 
The animals were euthanized at the National Veterinary Institute at DTU, Denmark, by an 119 
overdose of pentobarbital and jugular puncture. All handling of animals was performed by 120 
trained personnel and veterinarians and fulfilled the regulations from the Danish Ministry of 121 
Justice. 122 
Content from the stomach and middle jejunum was collected in sterile tubes and were snap 123 
frozen in dry ice before storage at -80 °C. Contents from terminal ileum were collected in 124 
sterile tubes and mixed 1:1 with 50 % w/w glycerol before snap freezing in dry ice and stored 125 
at -80 °C. The use of frozen compared to fresh samples has formerly been verified (33, 34) and 126 
frozen samples have previously been used in similar experiments (35, 36). 127 
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3.3 Characterization of digestive enzymes 128 
Stomach and jejunal contents were homogenized followed by centrifugation at 4000g for 10 129 
min at 4 °C, and the pH in the supernatant was then measured using a pH-strip (pH-fix, 130 
Macherey-Nagel, Germany). Dry matter was determined by drying at 105 °C for 24 hours in 131 
duplicate for each sample. 132 
Pepsin in the stomach supernatant was assayed by incubating 50 µL supernatant in 250 µL 0.06 133 
M HCl with 20 g/L hemoglobin in triplicate for each sample. The reaction was run at 37°C at 134 
900 RPM and terminated after 60 min with 500 µL of 5 % w/v trichloracetic acid. After 10 min 135 
of mixing, the samples were centrifuged for 2 min at 14000g and 100 µL of the supernatant was 136 
measured at 280 nm. Controls were made by adding the trichloracetic acid before the gastric 137 
sample. Units were defined as nmol tyrosine released per minute using an extinction coefficient 138 
of 1250 M-1cm-1. Pepsin concentration was calculated by comparing the activity to a standard 139 
curve of commercial pepsin [P7125, #SLBB6557V] (Sigma-Aldrich, Steinhein, Germany). 140 
Small intestine proteases in the jejunal supernatant were assayed with an AZCL-casein assay 141 
(Megazyme, Bray, Ireland) according to the manufacturer’s instructions with some 142 
modifications: 50 µL of 40-fold diluted sample was added to 250 µL McIlvaine buffer (pH 7, 143 
20 mM) containing 5 mg AZCL-casein in triplicate for each sample. The reaction was run at 37 144 
°C at 1400RPM and terminated after 5 min with 500 µL of 10 g/L trisodium phosphate. After 145 
centrifugation for 5 min at 15000g, 100 µL of the supernatant was measured at 590 nm in a 146 
microplate. Units were defined by a change in 1 OD at 1 cm path length per minute. The 147 
corresponding concentration of pancreatin was compared to a standard curve of commercial 148 
pancreatin [P7545, #SLBD0640V] (Sigma-Aldrich, Steinhein, Germany). 149 
           8 OF 36 
 
3.4 Production of in vitro solubilized fiber 150 
A porcine gastrointestinal digestion process was simulated by sequential digestion in stomach 151 
conditions and then small intestinal conditions, producing in vitro solubilized fiber (IVSF). The 152 
concentrations and conditions were based on the measurements from characterization of the 153 
animal digesta. The potato pulp used in the study, FiberBind, was kindly provided by KMC 154 
(Brande, Denmark), and is the dried residue remaining when potato starch has been extracted. 155 
10 mL of purified water with 0.32 mg/mL pepsin (Sigma, P7125) was added to 300 mg 156 
FiberBind in a 50 mL falcon tube and adjusted to pH 3 with HCl in four replicates. After 157 
preheating to 39 ºC, pectin lyase and polygalacturonase was added corresponding to 0-0.05 % 158 
E/S each and the mixture was incubated at 60RPM on a rolling mixer situated in an oven at 39 159 
°C. After 60 min, 20 mL of preheated water containing 16 mg/mL pancreatin, 50 mM 160 
bicarbonate and 2 mg/mL bile salts were added, making the pH ~7. This was further incubated 161 
at 60 min at 60RPM. The tubes were placed on ice for 5 min to stop the reaction and were 162 
centrifuged at 4000g for 5 min at 4 °C, after which they were filtered through a qualitative filter 163 
paper no. 417 (VWR, Darmstadt, Germany). 10 mL of the filtrate was added to 23.3 mL 164 
isopropanol to precipitate the soluble carbohydrates and the mixture was centrifuged at 4000g 165 
for 5 min. The supernatant was discarded and the pellet was lyophilized and weighed.  166 
3.5 Production of ultrafiltered soluble fiber 167 
Ultrafiltered soluble fiber (UFSF), mimicking the one produced in Thomassen et al. (26) was 168 
made by adding 10 g of FiberBind to 1000 mL 0.1M phosphate buffer, pH 6, and preheating to 169 
60 °C. 1 % E/S of each polygalacturonase and pectin lyase was added and the reaction was run 170 
for 1 min at 300RPM, after which the reaction was stopped by 10 min of boiling. The solution 171 
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was then centrifuged at 5000g for 60 min and the supernatant was ultrafiltered with a 100 kDa 172 
VivaFlow 200 filter (Vivascience, Hannover, Germany) with the addition of 5 L of water until 173 
90 mL remained in the retentate. The carbohydrate in the retentate was then precipitated by 174 
addition of isopropanol to 70 %v/v and the mixture was centrifuged at 4000g for 5 min. The 175 
pellet was then lyophilized.   176 
3.6 Carbohydrate composition 177 
Monosaccharide composition analysis was done as described in Ravn et al. (37). In brief, 178 
samples were hydrolyzed by trifluoroacetic acid (soluble carbohydrate) or sulfuric acid 179 
(FiberBind), followed by quantification on a HPAEC-PAD system using a Dionex CarboPac 180 
PA1 analytical column (2 mm × 250 mm) combined with a CarboPac PA1 precolumn (2 mm × 181 
50 mm) and 0.25-500 mM NaOH (37). Rhamnose, arabinose, galactose, glucose, mannose, 182 
xylose and galacturonic acid were included as standards. 183 
Size determinations were done by dissolving carbohydrate samples at 3 g/L in 0.1 M sodium 184 
acetate, pH 6, with 0.02 % sodium azide and filtering with a 0.22 µm filter. Samples where then 185 
injected in Shodex OHpak SB-806 HQ (8.0 mm × 300 mm) column (Showa Denko KK, 186 
Kawasaki, Japan), and eluted with 0.1 M sodium acetate (pH 6). The injection volume was 50 187 
µL and the flow rate was 0.5 mL/min at 30 °C on a system consisting of a P680 HPLC pump 188 
and an ASI-100 automated sample injector using a refractive index detector Shodex RI-101 189 
(Showa Denko KK). Pullulan standards of 1.3, 10, 110, 400 and 800 kDa were used. 190 
3.7 Protein determination 191 
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The concentration of soluble protein in the extracted fibers was estimated using Micro BCA 192 
Protein Assay Reagent kit (Pierce, Rockford, IL) as per the manufacturer’s instructions with 193 
BSA as a standard. 194 
3.8 In vitro fermentations 195 
A fiber product was produced in the GI-reactor to simulate an in situ production of what would 196 
be expected to reach the terminal ileum in an animal if fed with enzymes and FiberBind. This 197 
fiber was then fermented in small scale fermentations by the method of Vigsnæs et al. (35, 36). 198 
Briefly, in vitro solubilized fiber (IVSF) from the simulated gastrointestinal reactor was 199 
fermented for 24 hours at a final concentration of 0, 2.5, 5 or 10 g/L (groups control, IVSF-2.5, 200 
IVSF-5 and IVSF-10, respectively) to a glucose-free media consisting of 2 g/l peptone water, 1 201 
g/l yeast extract, 0.1 g/l NaCl (1.71 mM), 0.04 g/l (0.23 mM) K2HPO4, 0.04 g/l (0.29 mM) 202 
KH2PO4,0.01g/l (0.04 mM) MgSO4∙7H2O, 0.01 g/l (0.07 mM) CaCl2∙2H2O, 2 g/l (23.81 mM) 203 
NaHCO3, 0.5 g/l bile salts, 0.5 g/l L-cysteine hydrochloride, 0.005 g/l hemin, 10 μl/l vitamin 204 
K1 (0.02 mM), 2 ml/l Tween 80 and 0.05 ‰ (w/v) resazurin. Inulin (INU) (Orafti®HPX, 205 
Orafti, Oreye, France), as well as an ultra-filtered soluble fiber (UFSF), both added at 5 g/L 206 
(INU-5 and UFSF-5, respectively), were used as positive controls. The fibers were dissolved 207 
with 15 min of agitation in a boiling water bath, having the added advantage of sterilizing the 208 
fibers which were contaminated with Bacillus cereus as well as other bacteria. The samples 209 
from the terminal ileum of piglets, stored in 25 % glycerol, were thawed on ice, pooled and 210 
diluted 5-fold in 10 mM de-gassed PBS. Digesta were pooled across piglets as in earlier studies 211 
(34, 38, 39), in order to control biological variation (40). This mixture was diluted 10-fold in 212 
the fiber-containing media, which had been de-gassed in an anaerobic cabinet overnight in 213 
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Nunc 14 mL round bottom tubes. The resulting 1 % solution of ileal content was then 214 
fermented for 24 hours in an anaerobic cabinet at 37.5 °C. All treatments were performed in 10 215 
replicates. A fermentation harvested immediately after inoculation, and with no added fiber, 216 
served as a baseline control, also in 10 replicates.  217 
3.9 pH and organic acid analysis 218 
Following the fermentations, tubes were centrifuged for 5 min at 5500g at 4 °C and pH was 219 
measured with a pH-meter. The sample was then re-suspended and transferred to a 2 mL 220 
Eppendorf tube, which was spun at 13.000g for 10 min. The supernatant was then filtered with 221 
a 0.22 µm filter and assayed for OA using high-pressure liquid chromatography (HPLC). The 222 
system was a Shimadzu HPLC fitted with an RSpak KC-811 column, using 12 mM H2SO4 with 223 
a flow rate of 0.6 mL/min at 63 °C and a refractive index detector. The standards used were 224 
lactic acid, acetic acid, propionic acid, iso-butyric acid, n-butyric acid, iso-valeric acid and n-225 
valeric acid. 226 
3.10 DNA extraction 227 
Fermentation samples were spun at 13.000g for 10 min, and the DNA contained in the cell 228 
pellets was purified with the Maxwell® LEV Blood DNA Purification Kit (Promega 229 
Corporation, Madison, WI, USA) as described in Ingerslev et al. (41).  230 
3.11 16S rRNA gene PCR 231 
PCR was performed targeting the V1/V2 regions of the bacterial 16S rRNA gene from the 232 
bacteria contained within the fermentations. The PCR was performed using the universal 233 
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primers V1-forward (5’-AGAGTTTGATCCTGGCTCAG-3’) and V2-reverse (5’-234 
CTGCTGCCTYCCGTA-3 ’) (42) (Sigma-Aldrich, Broendby, Denmark). Both primers were 235 
5’-barcode tagged (6-nt) and each specific barcode were assigned a specific DNA sample. The 236 
reaction was carried out in 50 µl reactions containing 5 µl of 5 x Goldtaq buffer (Applied 237 
Biosystems, Branchburg, NJ, USA), 1 µl of each primer (20 µM), 2 µl of 10 mM dNTP, 4 µl of 238 
25 mM MgCl2, 0.5 µl of AmpliTaq Gold® polymerase (Applied Biosystems), 34.5 µl of 239 
nuclease-free H2O and 2 µl of DNA template (10 ng/µL). Reaction times and cycling 240 
conditions were 94°C for 6 min, 30 cycles of  94 °C for 45 s, 57 °C for 45 s, 72 °C for 90 s and 241 
72 °C for 10 min. The resulting PCR products were then analyzed on an Agilent 2100 242 
Bioanalyzer using the Agilent DNA 1000 kit (Agilent Technologies, Waldbronn, Germany) and 243 
further pooled in equimolar ratios [50 ng per barcoded sample]. The pooled DNA was then 244 
purified for primers and detergents using a Qiagen MiniElute PCR purification kit (Qiagen 245 
GmbH, Hilden, Germany) according to the manufacturer’s instructions.  246 
3.12 Illumina MiSeq sequencing 247 
The DNA was submitted to the National High-throughput DNA Sequencing Centre at 248 
University of Copenhagen, Denmark, for sequencing on an Illumina MiSeqTM 250PE platform. 249 
The obtained long reads were analyzed using the BION-meta software (for more information 250 
about BION-meta and for acquisition of software, see http://box.com/bion). In brief, de-251 
multiplexing was performed according to the primer- and barcode sequences. Forward and 252 
reverse sequences were joined, allowing no gaps, a maximum mismatch percentage of 80, and 253 
a minimum overlap length of 20 bp. Next, the sequences were cleaned at both ends by removal 254 
of bases of a quality less than 98 %, which is equivalent to a Phred score of 17. Identical 255 
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sequences were further de-replicated into consensus sequences. Consensus sequences of at least 256 
260 nucleotides in length were mapped into a table according to the individual barcodes. 257 
Finally, the consensus sequences were taxonomically classified against the Ribosomal Database 258 
Project II (RDP-II) SSU database (RDP II; http://rdp.cme.msu.edu/index.jsp) using a word 259 
length of 8 and a match minimum of 90 %. The top one percent of the obtained similarities 260 
from the RDP-II database was used for taxonomical classification of the consensus sequences. 261 
The resulting operational taxonomic units (OTUs) in each barcoded sample were normalized in 262 
order to enable direct statistical comparisons of relative abundance in each sample.  263 
3.13 Statistics 264 
The dose-response relationship of enzyme dosage versus dry matter release in the intestinal 265 
reactor was fitted to a modified Monod equation of the form %release = φ1 + φ2*[E]/ (φ3 + [E]). 266 
Analysis of variance was used to evaluate significant differences in dosage. pH and organic 267 
acid concentrations were analysed with an ANOVA followed by Tukeys test with the fiber 268 
treatment as the main effect using the lm- and HSD.test-procedures in R. Two-way ANOVAs in 269 
the fiber composition and organic acid data were avoided due to uneven variances, and instead 270 
adjustment for multiple comparisons when doing multiple one-way ANOVAs were made with 271 
the Sidak correction. Sequencing data was analysed on a given taxonomic level by ANOVA on 272 
log-transformed data followed by Tukeys post-hoc test, followed by correction for multiple 273 
comparisons by the Sidak correction (43) when comparing multiple OTUs. The microbial 274 
community was analysed by subjecting species-level data to principal coordinates analysis 275 
(PCoA) with treatment groups as constraints and using the Bray-Curtis dissimilarity index 276 
using the capscale-procedure in R, followed by analysis of similarities (anosim-procedure) as 277 
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well as k-means clustering (kmeans-procedure). Shannon-indices were calculated by the 278 
diversity-command. Principal coordinates regression, e.g. using the scores from the first axis of 279 
the PCoA as a predicting variable, was used to compare overall bacterial composition with 280 
individual OAs. 281 
4 Results 282 
4.1 Characterization of piglet digestive parameters 283 
The dry matter content, the pH and the pepsin levels in the stomach digesta was determined in 284 
order to use the values to produce a realistic in vitro GI-system. There was substantial variation 285 
within the piglets, especially in the activity of pepsin, which on average was 43.3 units/mL 286 
digesta (pooled SD 3.3), but ranged from 13.4 to 98.1 units/mL digesta. Dry matter was 21.42 287 
%w/v, ranging between 6.78 and 30.65 %w/v, whereas pH averaged 4.16 and ranged from 4.1 288 
to 4.6.  289 
The protease content in the ileum was 39.2 units/mL digesta (pooled SD 1.32) and ranged from 290 
7.0 to 78.0 units/mL. Dry matter content in the ileum was, on average, 13.4 %w/v (range 7.28-291 
19.30) and the pH was 6.6 (range 6.0-7.0). 292 
4.2 In vitro GI reactor 293 
The reactor was set up on the basis of the measurements from the piglet digesta with an 294 
additional overhead. The protease content in particular was deemed to be of importance, and 295 
therefore protease was added to equal twice the highest measured concentration for both the 296 
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stomach and small intestine step. The lowest measured pH in the stomach was 3.5 and therefore 297 
the pH used in this step was 3. pH in the small intestine was set to be neutral (pH 7).  298 
The activity of the polygalacturonase and the pectin lyase at stomach conditions (pH 3) were 299 
22.70 U/mg and 0.02 U/mg, respectively. In small intestine conditions (pH 7), the activity was 300 
18.79 U/mg and 2.38 U/mg, respectively 301 
4.3 Characterisation of IVSF and UFSF 302 
The release of water-soluble fibers from potato pulp showed a clear dose-dependency as a 303 
function of enzyme dosage, which could be modelled by a non-linear 3-parametric equation, 304 
which in turn suggested that the maximal release was 26.9 % of the initial dry matter. 5.56±0.1 305 
% of initial dry matter was released without addition of pectinolytic enzymes and since less 306 
than 20 % of this fraction could be accounted for by HPAEC-PAD or as protein, it presumably 307 
consists of various proteins, lignin and salts. The composition of all other fractions released 308 
contained high amounts of galactose, galacturonic acid and to a smaller degree, arabinose and 309 
rhamnose. Analysis of variance on the data revealed that there was a plateau in yield at dosage 310 
0.05 % E/S, for which reason 0.03 % E/S was chosen as a cost-beneficial dosage to do future 311 
work with. At this dose, 24.6 mg dry matter is released from 100 mg FiberBind, corresponding 312 
to 9.5 mg galactose. The composition of in vitro released fiber, IVSF, and UFSF is shown in 313 
Table 1, and it is seen that IVSF contain more galacturonic acid and less galactose than UFSF 314 
as well as slightly more protein. UFSF also contain a small amount of mannose, presumably 315 
from the pectinase formulation. HPSEC-analysis of IVSF revealed a molecular size distribution 316 
with two distinct peaks, notably a large fraction of ~900 kDa as well as a smaller fraction at 317 
~10 kDa (Figure 1). The HPSEC chromatogram of the UFSF showed that large molecular 318 
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weight polysaccharides >800 kDa were much more abundant than the smaller fractions. 319 
Estimation of the amount of monosaccharide was done by comparing area under the curve 320 
(AUC) of the monosaccharide peak (24.6 min) with the total AUC. The AUC of the 321 
monosaccharide peak constituted ~3.8 % of the total AUC in the UFSF, while this number was 322 
10.6 % in the IVSF, suggesting that the monosaccharide content was 2.8 fold higher in the 323 
IVSF. 324 
4.4 In vitro fermentation characteristics 325 
IVSF, UFSF and inulin were fermented in an in vitro reactor for 24 hours in the terminal ileal 326 
content from piglets. The fermentations resulted in a fiber dose dependent decrease in pH 327 
(p<0.0001, general linear model) as shown in Figure 2. Fermentation INU-5 group resulted in 328 
the same pH as the fiber at IVSF-5 (p=1, tukeys post-hoc test), although the pH was not as low 329 
as in the IVSF-10 fermentation. The UFSF-5 treatment induced a similar pH as the INU-5 and 330 
IVSF-5 groups, but a higher pH than the IVSF-10 group. 331 
4.5 Organic acids 332 
The fibers were all highly fermentable. Fermentation treatment had a significant effect on all 333 
organic acids (Table 2) (ANOVA, p<0.001). Total OA markedly increased with concentration 334 
of IVSF, and INU and UFSF-5 resulted in OA levels in-between IVSF-2.5 and IVSF-5 levels. 335 
Especially lactic acid was markedly increased by the experimental fiber, 20x from baseline and 336 
significantly higher than INU-5. Lactate was also the most affected OA relatively speaking, 337 
constituting 3 % of total OA at control and 17 % in IVSF-10. Propionate increased with dosage, 338 
although levels plateaued beyond IVSF-5. Both butyrate and valerate increased from baseline 339 
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with all treatments, although the only treatment statistically different from others were the 340 
IVSF-2.5 treatments. Acetate increased with IVSF concentrations, as well as with INU-5 and 341 
UFSF-5. As expected, a highly significant correlation (r2 =0.94, p<0.00001) existed between 342 
total OA and pH.  343 
4.6 Microbiota composition 344 
After MiSeq sequencing of the 16S rRNA PCR products followed by pattern de-multiplexing, 345 
sequence cleaning, uniqification and chimera filtering by the BION software, 1,279,205 346 
sequences were available for taxonomical classification. 347 
On phylum level, the samples were generally heavily dominated by phylum Firmicutes. The 348 
native microbiota, e.g. the baseline samples, consisted of more than 97 % Firmicutes, with the 349 
classes Bacilli, Clostridia and Erysipelotrichia accounting for for 47, 33 and 17 % of the total 350 
reads, respectively.  Fermentation for 24 hours without added fiber resulted in increasing levels 351 
of the class Clostridia even no-fiber control group, whereas the presence of the in vitro 352 
solubilized fibers was associated with a rise in the class Negativicutes. Incubation with INU-5 353 
resulted in a decrease of class Clostridia and an increase in class Negativicutes, whereas the 354 
UFSF-5 incubation eliminated the class Clostridia entirely whilst increasing class Bacilli and 355 
class Negativicutes.  356 
On the genus level (see Figure 3), the in vitro made fibers caused a significant decrease in 357 
Streptococcus and a significant increase in Lactobacillus. Clostridium did not change 358 
significantly from control with IVSF although it was decreased significantly in INU-5 and 359 
UFSF-5. Clostridium perfringens were found in all groups, but was not changed by addition of 360 
IVSF, although it was depressed significantly by INU-5 and UFSF-5. No clostridium difficile 361 
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were found in any of the groups. Clostridium cluster XIVa was only found in the order of 90 362 
reads out of more than a million total reads. Olsenella was only elevated in the IVSF-2.5 and 363 
IVSF-5 groups. The ratio of genus Clostridium to genus Lactobacillus was markedly 364 
heightened in the control treatment, but was not different between other treatments. Excluding 365 
the control group from the analysis to retain homoscedasticity suggested that the IVSF-10 366 
group had a higher ratio of these two genera than UFSF-5, mainly since Clostridium here was 367 
very low. The genus Megaspheara was increased significantly by all fiber treatments except the 368 
IVSF-2.5 treatment. Enterobacteriaceae was present in all baseline samples, and increased 369 
from baseline in all fermentations including the control, although the amounts in INU-5 and 370 
UFSF-5 groups were slightly lowered from the control. Bifidobacteria were only consistently 371 
observed in the INU-5 treatments, and only constituted less than ~0.1 % 372 
On a genus level, the Shannon diversity index was significantly lower in the control and UFSF-373 
5 groups compared to the baseline, IVSF-2.5, IVSF-5, IVSF-10 and INU-5 groups had 374 
significantly higher indices. A constrained analysis of coordinates (CAP) on species-level data 375 
with the treatment groups as constraints resulted in 71.1 % of the variation being explained on 376 
the first two dimensions as seen in Figure 4. On the first axis, Lactobacillus spp. as well as 377 
Megasphaera spp. had positive coefficients, whereas species of Clostridium, Streptococcus 378 
hyointestinalis and Erysipelotrichaceae turicibacter had negative coefficients. On the second 379 
axis, Streptococcus hyointestinalis, Lactobacillus delbrueckii and unclassified Turicibacter had 380 
positive coefficients, whereas various species of Clostridium and unclassified Lactobacillus had 381 
negative coefficients. Clustering by the k-means algorithm showed distinct clusters, namely one 382 
containing UFSF-5, one with INU5, a third cluster containing IVSF-5 and IVSF-10 treatments 383 
and fourth one containing the CON group. In contrast, the IVSF-2.5-group was not clearly 384 
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clustered, and although the control samples were clearly separated on the first axis, there was 385 
no separation on the second. The clustering was supported by analysis of similarities (R =0.811, 386 
p<0.001). 387 
The scores obtained from the constrained analysis of principal coordinates were further used as 388 
an independent variable to test correlations with pH and the OA composition using linear 389 
regression (Figure 5). A significant negative association between the score on dimension 1 390 
(CAP1) was observed from pH and acetic acid, whereas there was a positive association of 391 
lactic acid, butyric acid and valeric acid. This, in turn, suggest that a gut microbiota rich in 392 
species belonging to genera Lactobacillus and Megasphaera and poor in genera Clostridium is 393 
associated with a low pH and acetic acid, but high levels of butyric, valeric and lactic acid. 394 
5 Discussion 395 
In the present paper, the solubilization of potato galacto-rhamnogalacturonan 1 from potato 396 
pulp was attempted in a piglet upper gastrointestinal simulated system. The operating 397 
parameters of the system were chosen from direct measurements on piglets. The pH of the 398 
stomach and the small intestine was measured to be 4.1-4.6 and 6.0-7.0, respectively, which is 399 
in agreement with literature reports (44). A pH of 3.0 was chosen as the stomach-value as this 400 
level of acidity is realistic in piglets eating little or after overnight fasting (45, 46). Proteolytic 401 
activity, which can potentially degrade the pectinolytic enzymes, was added to mimic the 402 
measured values, as literature values are not directly applicable due to differences in methods 403 
and definition of units. The release of water soluble fiber from the potato pulp required very 404 
little enzyme, in the order of 30 µg of each enzyme (0.03 % E/S) releasing ~21 % of the dry 405 
matter from 300 mg FiberBind. Beyond 90 µg of each enzyme, there was no further release. 406 
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The two monocomponent enzymes were not purified beyond ultrafiltration before use, so even 407 
lower doses may be feasible as the enzyme dose was determined from total protein after Pichia 408 
fermentation. Previous reaction schemes have involved a 1 % E/S, which would correspond to 409 
3 mg of each enzyme, approximately 33 times as much (26, 27), making in situ production an 410 
attractive possibility.  411 
The monosaccharide composition of the released fractions suggest that this was indeed galacto-412 
rhamnogalacturonan 1, corresponding to a backbone of rhamnose and galacturonic acid and 413 
being highly substituted with galactose chains as well as smaller amounts of arabinose, likely 414 
being flanked by domains of homogalacturonan (28, 47). The UFSF was different from the 415 
IVSF in that the galactose content was higher and the galacturonic acid content was lower. 416 
According to HPSEC-analysis, both fibers encompassed two separate populations of the 417 
solubilised pectin, namely high and low molecular weight fractions. The UFSF-fiber, being 418 
higher in molecular weight as well as galactose, can then be hypothesized to be richer in 419 
galactan-rich RG1-fractions and lower in shorter polygalacturonan chains, which would have 420 
been filtered out in the ultrafiltration step as in the UFSF product. The content of 421 
monosaccharide was also higher in the IVSF than the UFSF.  The existence of a dual 422 
population in enzymatically solubilized potato pectin has previously been shown (26). An 423 
additional difference is the presence of mannose in the purified fiber, which presumably comes 424 
from the enzyme preparation, e.g. as cell wall material from Pichia pastoris. Mannose has been 425 
detected (3-5 %) in similarly produced fiber (26, 48), and appears to be >10 kDa in size.  426 
The pH of the incubations followed a dose-dependent pattern, dropping up to 2.5 pH-points 427 
when incubated with 10 mg/mL of IVSF for 24 hours. There are few in vitro fermentation 428 
studies reported using porcine ileal microbiota, but pH was reported to drop from 6.63 to ~6.2 429 
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and ~5.7, respectively, by fermenting 5 or 10 g/L of predigested feed containing various 430 
oligosaccharides in pig feces (22). Another study used various human milk oligosaccharides 431 
(HMO), inulin and GOS at 1 mg/mL in sow-reared or formula fed piglet colonic contents, and 432 
reported pH drops from 6.5 to 5.3 after 12 hours (38). Incubations of 10 g/L inulin or 433 
transgalacto-oligosaccharides (TOS) in pig GI-contents for 4 hours, showed a drop from 6.5 to 434 
6.3 in distal small intestine content, but a drop onto 5.8 for colonic content (49). pH-values 435 
reported from in vivo studies in the terminal ileum has been reported from 7.8-8.3 (48) to 5.7-436 
6.0 (50), suggesting that the low pH-values observed in the in vitro fermentation studies may be 437 
lower than physiologically relevant. Colonic pH has been reported as 6.8, regardless of diet 438 
(51), suggesting that clearance of fatty acids, which does not occur in vitro but is substantial in 439 
the colon (52), has a stabilizing effect on pH.  440 
The fibers in this study showed excellent fermentability, evident by the increase in organic 441 
acids (see Table 2). The exact role of the individual fatty acids in piglet health is not entirely 442 
clear, but there is general consensus in that butyric acid is both a fuel as well as a trophic factor 443 
for colonocytes, whereas propionate and acetate enter circulation and participate in hepatic 444 
energy production (53–55).  Interestingly, the control sample, which was 24 h incubation 445 
without fiber, showed increases in acetate and propionate, probably reflecting fermentation of 446 
residual material from digesta or the glycerol added at freezing. Of further interest are the 447 
relatively high levels of lactate and the apparent dose-response relationship observed in the 448 
IVSF-series and the UFSF-5 group, suggesting that this is a fermentation product of lactic acid 449 
bacteria. The high levels of lactic acid bacteria in these treatment groups support this notion 450 
(see Figure 3) as well as the correlations of CAP1 and lactate as seen in Figure 5. When 451 
fermenting inulin (56) or xylooligosaccharides (21), lactate is present after 11.5 hours, is 452 
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markedly lowered after 30 hours, and undetectable after 72 hours, presumably since lactate is 453 
metabolized into other organic acids such as propionate through the acrylate pathway (55).  454 
The composition of the microbiota was almost exclusively composed of the phylum 455 
Firmicutes, which is in contrast to other published pig metagenomics – in a study by 456 
Lamendella (57), the Firmicutes and the Bacteroidetes phylum constituted 40-60 % and 25-40 457 
%, respectively, depending on the sequencing platform and the classification database. This 458 
was, however, fecal samples from adult pigs. A more recent study using piglets weaned at 28 459 
days and fed for 31 days, showed 75 % Firmicutes, 15 % Bacteroidetes and small amounts of 460 
the phylum Proteobacteria in fecal samples. Looft et al. (2012), in an antibiotic feeding study 461 
with piglets weaned at 21 days and fed for 21 days, had contrasting results: 20 % Firmicutes, 462 
50 % Bacteroidetes and ~10 % Proteobacteria (58). A study from the same group reported ~20-463 
30 % Firmicutes and 50-60 % Bacteroidetes in animals weaned at 12 days and tested at 8 464 
weeks (59). One explanation for the dominance of Firmicutes in our study is the use of terminal 465 
small ileum samples rather than fecal samples, supported by a recent study examining the 466 
microbiota composition in several segments of the porcine GI - here the ileal microbiota was 467 
~95 % Firmicutes, whereas the cecal, colonic and fecal flora was ~50 % Bacteroidetes (30).  468 
The composition of the microbiota in the baseline group, e.g. the microbial composition in the 469 
native piglet, was dominated by the genera Streptococcus (42±6 %), Clostridium (27±7 %), 470 
Turicibacter (15±2 %) and Lactobacillus (5±0.5 %).  The Turicibacter populations, a genus 471 
previously found in the ileum of piglets (60), but only isolated from a human patient with acute 472 
appendicitis (61), were close to entirely attenuated in all 24 hour fermentations, suggesting that 473 
this genus requires host interaction or have specific growth requirements. Merely incubating the 474 
bacteria for 24 hours resulted in a shift towards a microbiota consisting of equal amounts of 475 
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Clostridium and Streptococcus. All the fiber treatments apart from UFSF-5 resulted in a higher 476 
bacterial diversity as evident by the Shannon index. The UFSF-5 group was almost exclusively 477 
composed of species of Lactobacillus, Veillonella, Megaspheara and Streptococcus. 478 
Addition of UFSF resulted in a significant increase in the genus Lactobacillus, believed to be 479 
beneficial (10), along with a significant decrease in genus Strepotococcus and a nonsignificant 480 
increase in genus Clostridium. Furthermore, Clostridium was substantially and significantly 481 
depressed with both INU-5 and UFSF-5 treatment. A point of main interest is the difference 482 
between microbial community composition in the IVSF-5 group and the UFSF-5 treatment 483 
groups, as these were supposedly chemically identical but resulted in markedly different 484 
microbiota profiles. The UFSF-5 group did however have 25 % more galactan and half the 485 
galacturonic acid content, which suggests that the galactan chains of the molecule has a more 486 
pronounced effect on genus Lactobacillus, whereas the galacturonic acid chains may be favored 487 
by bacteria belonging to the genus Clostridium. It has previously been shown that, in human 488 
feces, pectin fractions with neutral sugars were efficient in increasing Bifidobacterium, whereas 489 
Clostridium was increased by polygalacturonic acid as enumerated by FISH (62). In contrast, 490 
another study using a pectin fraction with high levels of galacturonic acid showed little growth 491 
of clostridia and increased levels of Bifidobacterium also by means of FISH (63). 492 
The Clostridium spp. observed in these fermentations appear to be a normal part of the porcine 493 
healthy gut microbiota, as they were present in high numbers in the baseline group and grew to 494 
high numbers in the control group, an observation consistent with other studies in healthy 495 
animals (57, 60, 64, 65). In the absence of genuine illness the actual implications of 496 
Clostridium populations are difficult to discern, and whether or not the eradication of 497 
Clostridium as seen in the UFSF is a positive effect uncertain as well. Members of Clostridium 498 
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cluster XIVa, previously found in colon of piglets (38), were not found in these samples to any 499 
relevant extent, which could be due to this study using the contents of the terminal ileum rather 500 
than the colon. Moreover, this cluster appears to preferably colonize the mucus layer (66), 501 
whereas this study used the luminal content. Clostridium perfringens appear to be a problem in 502 
the neonatal animal (67), but less so in the weaning piglet where E. coli is the main pathogenic 503 
agent (6, 7). In this study, the amount of Enterobacteriaceae in the IVSF-series was not 504 
different from the control, although the amount was decreased from control in INU-5 and 505 
UFSF-5.  The observation that the genus Escherichia was higher in IVSF-5 than UFSF-5 can 506 
possibly be explained by the apparent 3 fold higher levels of monosaccharide in the IVSF-5 507 
group. Escherichia is well adapted to catabolism of monosaccharides, including galacturonic 508 
acid (68), and may have had an advantage in the early stages of the fermentation owing to the 509 
quick replication rate of this genus. 510 
Streptococcus spp. is also a normal component of the porcine gut microbiota, and in this study, 511 
it appeared to be diminished by both the in vitro made fiber and the UFSF-5. Since the 512 
abundance of Lactobacillus spp. where increased in these same groups, it is difficult to 513 
establish whether it is a direct effect of the fiber or through the Lactobacillus. The consequence 514 
of this alteration is unknown. 515 
Bifidobacterium, which are generally considered health-promoting, are ubiquitous in the human 516 
gut microbiota, but were not detected in notable numbers in neither the baseline samples nor 517 
after fermentation, and is reported to comprise a neglible portion of the pig intestinal 518 
microbiota (38, 69, 70). The importance of Bifidobacterium in the pig remains to be 519 
illuminated.  520 
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The genus Veillonella grew well in all treatments apart from baseline, likely owing to the fact 521 
that this genus metabolizes organic acids rather than carbohydrate (71). Bacteria belonging to 522 
the genus Megaspheara, including the species M. elsdenii suggested to protect the host against 523 
the pathogen Brachyspira hyodysenteriae (19), was another genus elevated by the fiber 524 
treatment in agreement with the fact that this genus feeds on organic acids (72). 525 
With the use of PCoA, the entire microbiota on a species level could be visualized as well as 526 
clustered. It was seen that there was marked clustering within each treatment group, but that 527 
groups IVSF-5 and IVSF-10 were closer to one another than any other group, and especially 528 
that the UFSF-5 group was far away from the IVSF-5 group, with which it should be 529 
chemically similar. This could be explained by small, but possibly key differences in the 530 
monosaccharide content (3.8 % vs 10.6 %) in the UFSF. The obtained scores, an aggregate 531 
measure of the bacterial composition, could furthermore be correlated with the levels of organic 532 
acids and pH, showing patterns in the production of fatty acids and microbiota, namely that a 533 
microbiota low in acetic acid, but high in butyric, valeric and lactic acid was associated with 534 
genera Lactobacillus and Megasphaera and but not with the genus Clostridium. 535 
For use in animal trials, it would appear that a treatment corresponding to IVSF-5 should be 536 
used, since a higher dose, IVSF-10, trended to have levels of Clostridium higher than the 537 
control. The UFSF fiber appeared to decrease bacterial diversity and it is unclear if having 60 538 
% Lactobacillus has a positive impact on the host. 539 
In conclusion, it has been established that targeted enzymatic catalysis can be used to extract 540 
the RG-1 domain of low value potato pulp in simulated in vitro digestion. Furthermore, the 541 
produced fiber was highly fermentable and capable of changing the microbial community when 542 
fermented in the contents of the terminal ileum of piglets, notably by increasing the 543 
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Lactobacillus counts. Whether the inter-animal variation is too large to verify a consistent 544 
response in vivo remains to be determined. For use in animal studies, a dosage corresponding to 545 
IVSF-5 may be a valid option.  546 
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8 Figure captions 801 
Figure 1: High performance size exclusion chromatogram of the fibers extracted from 802 
FiberBind by simulated in vitro digestion (IVSF) and by using an established purification 803 
process (UFSF). *: 800  kDa, +: 400  kDa, #: 110 kDa, ¤:12 kDa, §:1.3 kDa  804 
 805 
Figure 2: The pH-value as a function of treatment after 24 hours of in vitro fermentation of in 806 
vitro solubilized fiber (IVSF) at 2.5-10 mg/mL, 5 mg/mL inulin (INU-5) or 5 mg/mL 807 
ultrafiltered soluble fiber (UFSF-5). N=10, non-similar letters indicate significant differences. 808 
 809 
Figure 3: Genus-level composition of the microbial community after sequencing. DNA was 810 
sequenced from 24 hours in vitro fermentations of in vitro solubilized fiber (IVSF) at 2.5-10 811 
mg/mL, 5 mg/mL inulin (INU-5) or 5 mg/mL ultrafiltered soluble fiber (UFSF-5). N=9-10 in 812 
each group. 813 
 814 
Figure 4: Constrained analysis of principal coordinates plot on normalized bacterial reads on a 815 
species level using Bray-Curtis dissimilarities. The K-means method was used for clustering 816 
(95 % CI). DNA was sequenced from 24 hours in vitro fermentations of in vitro solubilized 817 
fiber (IVSF) at 2.5-10 mg/mL, 5 mg/mL inulin (INU-5) or 5 mg/mL ultrafiltered soluble fiber 818 
(UFSF-5). N=9-10 in each group. 819 
 820 
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Figure 5: Associations between pH and fatty acids versus bacterial flora (CAP1). All 821 
associations apart from propionate were significant (p<0.05, general linear model). pH and OA 822 
was measured and DNA was sequenced from 24 hours in vitro fermentations of in vitro 823 
solubilized fiber (IVSF) at 2.5-10 mg/mL, 5 mg/mL inulin (INU-5) or 5 mg/mL ultrafiltered 824 
soluble fiber (UFSF-5). N=9-10 in each group. 825 
 826 
 827 
 828 
 829 
 830 
 831 
 832 
 833 
 834 
 835 
 836 
 837 
 838 
 839 
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9 Tables 840 
Method Rha Ara Gal Glc Xyl Man GalA Protein N/A 
IVSF 3.4±0.4* 6.5±0.8 36.3±3.6* 2.4±0.4* 0±0 0±0* 20.3±5.0* 13.2±0.5* 17.9±0 
UFSF 2.4±0.1 5.4±0.3 45.6±1.5 4.7±0.4 0±0 6.7±0.2 9.3±0.2 10.7±0.4 15.2±0 
Table 1: The composition of the fibers extracted from FiberBind by simulated in vitro digestion 841 
(IVSF) and by using an established purification process (UFSF). Total dry matter release was 842 
determined by weighing after freeze-drying, and monosaccharide composition was determined 843 
by acid hydrolysis followed by HPAEC-PAD analysis. Protein was determined with a 844 
bicinchoninic acid-assay. N/A (non-accountable) is the fraction which could not be recovered 845 
by HPAEC-PAD or protein determination. All values are in w/w percent of released dry matter, 846 
monosaccharides were calculated as dehydrated values, n=4. * denotes significant differences 847 
across columns by t-test, p<0.05 after correction for multiple comparisons.  848 
 849 
Treatment Lactate Propionate Acetate Butyrate Valerate Total 
Baseline 0.41±0.04d 0.89±0.02e 2.53±0.05e 0.11±0.02b 0±0a 3.95±0.09f 
Control 0.84±0.09d 5.87±0.18d 19.73±3.17d 0.96±0.5ab 0.29±0.25a 27.69±4.15e 
IVSF-2.5 0.95±0.07cd 8.09±1.69c 22.25±1.92cd 3.65±2.85ab 1.4±1.21a 36.34±1.51d 
IVSF-5 4.23±0.69bc 11.79±0.63a 28.36±1.34ab 1.86±0.77ab 0.5±0.38a 46.73±1.22b 
IVSF-10 9.11±3.85a 10.77±1.51ab 30.5±5.09a 4.49±4.29a 1.52±1.92a 56.39±3.68a 
INU-5 2.21±0.86cd 10.3±0.63ab 26.08±1.86bc 2.72±1.49ab 0.94±0.69a 42.25±1.96c 
UFSF-5 6.19±3.6ab 9.56±0.59bc 23.57±1.75cd 3.22±2.23ab 0.95±0.89a 43.49±1.84bc 
 850 
Table 2: Concentrations of OA as a function of treatment after 24 hours of in vitro fermentation 851 
of in vitro solubilized fiber (IVSF) at 2.5-10 mg/mL, 5 mg/mL inulin (INU-5) or 5 mg/mL 852 
ultrafiltered soluble fiber (UFSF-5). Values are mmol/L, n=10 for each group. Non-similar 853 
letters denotes significant differences for each column by one-way ANOVA, p<0.05 after 854 
correction for multiple comparisons.  855 
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